Imunon, Inc.
IMNN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000749647
In the last 90 days, Imunon, Inc. insiders filed 0 open-market purchases and 2 sales; 23 institutions reported holding it in 13F filings for Q2 2026, worth $506.1K in total; no superinvestor holds it.
Key figures
- Market capClose on Nov 10, 2026
- $4.32M
- Insider buysOpen market, last 90 days
- 0
- Insider sellsLast 90 days, $7.94K in total
- 2
- 13F holdersQ2 2026, +4 vs. previous quarter
- 23
- 13F valueReported value at the end of Q2 2026
- $506.1K
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Financials
See financial statementsFrom SEC filings, in USD.
- Revenue, FY2025
- –
- No comparable prior period
- Net income, FY2025
- -$14.5M
- No comparable prior period
- Free cash flow, FY2025
- -$14.2M
- No comparable prior period
- Revenue, Q2 FY2026
- –
- No comparable prior period
Short interest
See short dataFrom FINRA, settlement date Oct 30, 2026.
- Short interest
- 215.6K
- Shares sold short
- Change
- +153.3K
- +245.8% vs. previous
- Days to cover
- 1.49
- At average daily volume
Superinvestors holding IMNN, Q2 2026
Go to the superinvestors tabNo superinvestor reported holding IMNN at the end of Q2 2026.
Latest insider trades
See all insider tradesOpen-market purchases and sales by Imunon, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 1, 2026 (view filing)4:06 PM ET | Aug 31 | 1 day | Eylward SusanGeneral Counsel and Corp Sec | SSale | −2.52K | $1.56 | −$3.95K | −46.6%2.90K after | |
| Aug 17, 2026 (view filing)4:17 PM ET | Aug 17 | Same day | Eylward SusanGeneral Counsel and Corp Sec | SSale | −2.45K | $1.63 | −$3.99K | −45.8%2.90K after | |
| Aug 4, 2026 (view filing)4:13 PM ET | Aug 3 | 1 day | Eylward SusanGeneral Counsel and Corp Sec | SSale | −2.54K | $1.57 | −$3.98K | −46.7%2.90K after | |
| Jul 21, 2026 (view filing)4:15 PM ET | Jul 20 | 1 day | Eylward SusanGeneral Counsel and Corp Sec | SSale | −2.15K | $1.78 | −$3.83K | −42.6%2.90K after | |
| Jul 7, 2026 (view filing)4:58 PM ET | Jul 6 | 1 day | Eylward SusanGeneral Counsel and Corp Sec | SSale | −920 | $1.88 | −$1.73K | −24.1%2.90K after | |
| Jun 29, 2026 (view filing) | Jun 29 | Same day | Eylward SusanGeneral Counsel and Corp Sec | SSale | −11.8K | $1.75 | −$20.6K | −80.3%2.90K after | |
| Jan 28, 2025 (view filing) | Aug 20, 2024 | 161 daysLate | Braun Donald PDirector | PPurchase | +25.0K | $1.18 | +$29.5K | +4,187.6%25.6K after | |
| Aug 16, 2024 (view filing) | Aug 15 | 1 day | Lindborg StacyPresident and CEO | PPurchaseImunon Common Stock | +25.0K | $0.98 | +$24.5K | +10.5%264.2K after | |
| Aug 16, 2024 (view filing) | Aug 15 | 1 day | Tardugno Michael HExecutive Chairman of Board | PPurchaseImunon Common Stock | +25.0K | $1.03 | +$25.8K | +7.6%353.3K after | |
| Apr 12, 2022 (view filing) | Apr 12 | Same day | Tardugno Michael HChairman, President and CEO | PPurchaseCelsion Corporation Common Stock | +4.00K | $3.53 | +$14.1K | +32.0%16.5K after |
Top 10 13F holders, Q2 2026
See all 23 holdersThe largest institutional positions in Imunon, Inc. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Armistice Capital, LLC | 144,767 | $257.7K | 0.01% | −203,563−58.4% | Reduced |
| Vanguard Capital Management LLC | 46,967 | $83.6K | 0.00% | −1,089−2.3% | Reduced |
| Geode Capital Management, LLC | 31,629 | $56.3K | 0.00% | −1,582−4.8% | Reduced |
| Virtu Financial LLC | 17,456 | $31.0K | 0.00% | +17,456 | New |
| Vanguard Fiduciary Trust Co | 13,269 | $23.6K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 10,342 | $18.4K | 0.00% | +10,342 | New |
| UBS Group AG | 5,203 | $9.26K | 0.00% | +4,628+804.9% | Added |
| BlackRock, Inc. | 4,464 | $7.95K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 3,952 | $7.04K | 0.00% | +2,086+111.8% | Added |
| Wells Fargo & Company | 3,342 | $5.95K | 0.00% | 00.0% | Unchanged |
Holders of 5% or more of IMNN
See all 1 holders and filingsHolders whose latest Schedule 13D or 13G filing reports 5% or more of Imunon, Inc..
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Armistice Capital, LLC | 13G/A | 9.99%450.3K shares | 0.00 ppfrom 9.99% | Feb 17, 20263 filings | Aug 14, 2026 | SEC |